The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors
Clinical trial NCT04805801 · UNKNOWN
Trial details
- NCT number
- NCT04805801
- Sponsor
- JW Pharmaceutical
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-28
- Primary completion
- 2024-07-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.